Cutaneous Neurofibroma: Clinical Trials

4 trials for Cutaneous Neurofibroma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 2
Phase 21Recruiting 1

Follow Cutaneous Neurofibroma: new trials by email Literature Review of Cutaneous Neurofibroma trials Research Report on Cutaneous Neurofibroma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
Imlygic - NF1, Neurofibromatosis
Phase 1RecruitingJohns Hopkins University102026-02-012026-05-08
Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
Mirdametinib - NF1, Cutaneous Neurofibroma
Phase 1 / Phase 2RecruitingJohns Hopkins University242024-02-122026-04-13
DPCP to Treat Cutaneous Neurofibromas Associated With NF1
DPCP - Cutaneous Neurofibroma
Phase 1CompletedNicholas Gulati172022-09-142024-05-06
Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas
Kybella, 1064nm laser, 755nm Alexandrite Laser - Cutaneous Neurofibroma
Phase 1CompletedMassachusetts General Hospital342021-06-022025-02-21

Narrower conditions

Neurofibromatosis 1 (3)  ·  Neurofibromatoses (2)  ·  Neurofibroma (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Heredodegenerative Disorders, Nervous System (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neoplastic Syndromes, Hereditary (3)  ·  Nerve Sheath Neoplasms (3)  ·  Nervous System Diseases (3)  ·  Neurocutaneous Syndromes (3)  ·  Neurodegenerative Diseases (3)  ·  Neuromuscular Diseases (3)  ·  Peripheral Nervous System Diseases (3)  ·  Neurofibroma (2)  ·  Nervous System Neoplasms (1)

Interventions

Deoxycholic Acid (1)  ·  Lasers (1)  ·  Lasers, Solid-State (1)  ·  diphenylcyclopropenone (1)  ·  mirdametinib (1)  ·  talimogene laherparepvec (1)

Sponsors

Johns Hopkins University (2)  ·  Massachusetts General Hospital (1)  ·  Nicholas Gulati (1)

Countries

United States (4)

Top investigators

Carlos Romo, MD (2)  ·  Nicholas Gulati, MD, PhD (1)  ·  R. Rox Anderson, MD (1)  ·  Rebecca Brown, MD, PhD (1)